169 related articles for article (PubMed ID: 8304580)
1. [Quality control of platelet concentrates. Functional assessment of stored platelets in vitro].
Groh J; Storck K; Kratzer MA
Anaesthesist; 1993 Dec; 42(12):847-55. PubMed ID: 8304580
[TBL] [Abstract][Full Text] [Related]
2. Suitability of measurement of swirling as a marker of platelet shape change in concentrates stored for transfusion.
Mathai J; Resmi KR; Sulochana PV; Sathyabhama S; Baby Saritha G; Krishnan LK
Platelets; 2006 Sep; 17(6):393-6. PubMed ID: 16973500
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the extent of platelet activation in platelet concentrates and in vitro and in vivo parameters.
Dijkstra-Tiekstra MJ; Pietersz RN; Huijgens PC
Vox Sang; 2004 Nov; 87(4):257-63. PubMed ID: 15585021
[TBL] [Abstract][Full Text] [Related]
4. A method for the quantitative assessment of platelet-induced clot retraction and clot strength in fresh and stored platelets.
Reid TJ; Snider R; Hartman K; Greilich PE; Carr ME; Alving BM
Vox Sang; 1998; 75(4):270-7. PubMed ID: 9873262
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution.
Diedrich B; Sandgren P; Jansson B; Gulliksson H; Svensson L; Shanwell A
Vox Sang; 2008 Feb; 94(2):96-102. PubMed ID: 18034788
[TBL] [Abstract][Full Text] [Related]
6. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.
Diedrich B; Ringdén O; Watz E; Shanwell A
Vox Sang; 2009 Oct; 97(3):254-9. PubMed ID: 19508669
[TBL] [Abstract][Full Text] [Related]
7. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
[TBL] [Abstract][Full Text] [Related]
8. [Storage of thrombocyte concentrates: quality control by in vitro bleeding test].
Glaser A; Böck M; Rüschemeyer G; Salat C; Heim MU; Hiller E; Mempel W
Infusionsther Transfusionsmed; 1993 Apr; 20(1-2):14-6. PubMed ID: 8504236
[TBL] [Abstract][Full Text] [Related]
9. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].
Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A
Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907
[TBL] [Abstract][Full Text] [Related]
11. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of autologous platelet transfusion in cardiac surgery: comparison of cryopreservation, blood collection on the day before surgery, and blood collection during surgery.
Yokomuro M; Ebine K; Shiroma K; Tamura S; Kumabe S; Ohtuki M; Suzuki H; Uchida S
Cryobiology; 1999 May; 38(3):236-42. PubMed ID: 10328913
[TBL] [Abstract][Full Text] [Related]
13. Novel methodology for assessment of prophylactic platelet transfusion therapy by measuring increased thrombus formation and thrombin generation.
Cauwenberghs S; Feijge MA; Theunissen E; Heemskerk JW; van Pampus EC; Curvers J
Br J Haematol; 2007 Feb; 136(3):480-90. PubMed ID: 17176266
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the correlation of platelet morphology with in vivo recovery and survival.
Mintz PD; Anderson G; Avery N; Clark P; Bonner RF
Transfusion; 2005 Aug; 45(2 Suppl):72S-80S. PubMed ID: 16086792
[TBL] [Abstract][Full Text] [Related]
15. Platelets of patients with peripheral arterial disease demonstrate a hypersensitive response to heparin.
Reininger CB; Greinacher A; Eibl-Eibesfeldt B; Lasser R; Steckmeier B; Schweiberer L
Int Angiol; 1996 Sep; 15(3):207-14. PubMed ID: 8971577
[TBL] [Abstract][Full Text] [Related]
16. Volume-reduced platelet concentrates.
Schoenfeld H; Spies C; Jakob C
Curr Hematol Rep; 2006 Mar; 5(1):82-8. PubMed ID: 16537051
[TBL] [Abstract][Full Text] [Related]
17. Platelet function testing to assess effectiveness of platelet transfusion therapy.
Salama ME; Raman S; Drew MJ; Abdel-Raheem M; Mahmood MN
Transfus Apher Sci; 2004 Apr; 30(2):93-100. PubMed ID: 15062745
[TBL] [Abstract][Full Text] [Related]
18. Pressure-aided transfusion of platelets: does it affect the platelets?
Fischer-Nielsen A; Stissing T; Maansson C; Joergensen BG
Transfusion; 2010 Feb; 50(2):361-5. PubMed ID: 19788509
[TBL] [Abstract][Full Text] [Related]
19. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
[TBL] [Abstract][Full Text] [Related]
20. In vitro assessment of platelet concentrates with multiple electrode aggregometry.
Shams Hakimi C; Hesse C; Wallén H; Boulund F; Grahn A; Jeppsson A
Platelets; 2015; 26(2):132-7. PubMed ID: 24999542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
